by South Australian Health and Medical Research InstituteCredit: AI-generated imageAn international clinical trial involving Adelaide researchers has demonstrated the safety and efficacy of a next-gen
by South Australian Health and Medical Research InstituteCredit: AI-generated imageAn international clinical trial involving Adelaide researchers has demonstrated the safety and efficacy of a next-gen
byGraeme Sneddon| News1 April 2022Patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test that is performed after treatment, accordi
byGraeme Sneddon| News1 April 2022Patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test that is performed after treatment, accordi
In a recent study published in theJournal of Experimental Medicine, researchers investigated whether bone marrow-derived cells with heterozygous loss of Dnmt3a (Dnmt3a+/Δ), the most common genet
In a recent study published in theJournal of Experimental Medicine, researchers investigated whether bone marrow-derived cells with heterozygous loss of Dnmt3a (Dnmt3a+/Δ), the most common genet
byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainPrimary liver cancer, the third-leading cause of cancer-related death worldwide, takes more than 30,000 lives in the Unite
byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainPrimary liver cancer, the third-leading cause of cancer-related death worldwide, takes more than 30,000 lives in the Unite
byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainTo investigate the long-term benefit of hormone-lowering treatment, researchers at Karolinska Institutet have done a 20-year follow-up of
byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainTo investigate the long-term benefit of hormone-lowering treatment, researchers at Karolinska Institutet have done a 20-year follow-up of
by Diane Dragaud, ECOG-ACRIN Cancer Research GroupCredit:LBA-1 Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblas
by Diane Dragaud, ECOG-ACRIN Cancer Research GroupCredit:LBA-1 Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblas
byBoston University School of MedicineCredit: CC0 Public DomainAfrican-Americans are at higher risk for cancer-associated venous thromboembolism (VTE) as compared with patients from other races.
byBoston University School of MedicineCredit: CC0 Public DomainAfrican-Americans are at higher risk for cancer-associated venous thromboembolism (VTE) as compared with patients from other races.
by University of Miami Leonard M. Miller School of MedicineCredit: Unsplash/CC0 Public DomainNew research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Me
by University of Miami Leonard M. Miller School of MedicineCredit: Unsplash/CC0 Public DomainNew research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Me
byNational University of SingaporeGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.006A research team from the National University of Singapore (NUS) has unearthed
byNational University of SingaporeGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.006A research team from the National University of Singapore (NUS) has unearthed